Mark Hillman — Hillman Capital Management, Inc.
Mark HillmanHillman Capital Management, Inc.
| Ticker | Company | Shares | Reported value | Portfolio weight |
|---|---|---|---|---|
| CVS | CVS Health Corp. | 55,475 | $5.7M | 4.2% |
| BIIB | Biogen Inc. | 23,993 | $5.2M | 3.8% |
| DD | DuPont de Nemours, Inc. | 37,745 | $5.1M | 3.7% |
| WBD | Warner Bros. Discovery, Inc. | 189,986 | $5.1M | 3.7% |
| BAX | Baxter International Inc. | 236,032 | $5.0M | 3.6% |
| IFF | International Flavors & Fragrances Inc. | 62,875 | $5.0M | 3.6% |
| GSK | GSK plc | 92,383 | $4.8M | 3.5% |
| KMX | CarMax, Inc. | 91,385 | $4.8M | 3.5% |
| BA | The Boeing Company | 21,574 | $4.7M | 3.4% |
| ZBH | Zimmer Biomet Holdings, Inc. | 53,943 | $4.6M | 3.4% |
13F filings are quarterly, published up to 45 days after quarter end, and report only long U.S.-listed equity positions. They are not a complete or current picture of any portfolio.